25 July 2022 false No description of principal activity Taxfiler 2024.1 10571823business:PrivateLimitedCompanyLtd2022-07-252023-07-24 105718232022-07-24 105718232022-07-252023-07-24 10571823business:AuditExempt-NoAccountantsReport2022-07-252023-07-24 10571823business:AbridgedAccounts2022-07-252023-07-24 105718232023-07-24 10571823business:Director12022-07-252023-07-24 10571823business:RegisteredOffice2022-07-252023-07-24 105718232022-07-24 10571823core:WithinOneYear2023-07-24 10571823core:WithinOneYear2022-07-24 10571823core:AfterOneYear2023-07-24 10571823core:AfterOneYear2022-07-24 10571823core:ShareCapitalcore:PreviouslyStatedAmount2023-07-24 10571823core:ShareCapitalcore:PreviouslyStatedAmount2022-07-24 10571823core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-07-24 10571823core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2022-07-24 10571823core:PreviouslyStatedAmount2023-07-24 10571823core:PreviouslyStatedAmount2022-07-24 10571823business:SmallEntities2022-07-252023-07-24 10571823countries:EnglandWales2022-07-252023-07-24 10571823core:MotorVehicles2022-07-252023-07-24 10571823core:FurnitureFittings2022-07-252023-07-24 10571823core:ComputerEquipment2022-07-252023-07-24 105718232021-07-252022-07-24 iso4217:GBP xbrli:pure
Company Registration No. 10571823 (England and Wales)
TRAFALGAR PHARMA LTD Unaudited accounts for the year ended 24 July 2023
TRAFALGAR PHARMA LTD Unaudited accounts Contents
Page
- 2 -
TRAFALGAR PHARMA LTD Company Information for the year ended 24 July 2023
Director
Rui Guo
Company Number
10571823 (England and Wales)
Registered Office
Concorde House Kirmington Business Centre, Limber Road Kirmington North Lincolnshire DN39 6YP
- 3 -
TRAFALGAR PHARMA LTD Statement of financial position as at 24 July 2023
2023 
2022 
Notes
£ 
£ 
Fixed assets
Intangible assets
87 
112 
Tangible assets
1,528 
1,530 
1,615 
1,642 
Current assets
Debtors
9,743 
9,937 
Cash at bank and in hand
5,065 
8,093 
14,808 
18,030 
Creditors: amounts falling due within one year
(22,607)
(22,807)
Net current liabilities
(7,799)
(4,777)
Total assets less current liabilities
(6,184)
(3,135)
Creditors: amounts falling due after more than one year
(65,672)
(65,672)
Net liabilities
(71,856)
(68,807)
Capital and reserves
Called up share capital
100 
100 
Profit and loss account
(71,956)
(68,907)
Shareholders' funds
(71,856)
(68,807)
For the year ending 24 July 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The members have agreed to the preparation of abridged accounts for the year in accordance with Section 444(2A).
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 24 April 2024 and were signed on its behalf by
Rui Guo Director Company Registration No. 10571823
- 4 -
TRAFALGAR PHARMA LTD Notes to the Accounts for the year ended 24 July 2023
1
Statutory information
TRAFALGAR PHARMA LTD is a private company, limited by shares, registered in England and Wales, registration number 10571823. The registered office is Concorde House Kirmington, Business Centre, Limber Road, Kirmington, North Lincolnshire, DN39 6YP.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Motor vehicles
- 25% on straight line basis
Fixtures & fittings
- 15% on cost
Computer equipment
- 33% on cost
Intangible fixed assets
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
4
Intangible fixed assets
Total 
£ 
Cost
At 25 July 2022
187 
At 24 July 2023
187 
Amortisation
At 25 July 2022
75 
Charge for the year
25 
At 24 July 2023
100 
Net book value
At 24 July 2023
87 
At 24 July 2022
112 
- 5 -
TRAFALGAR PHARMA LTD Notes to the Accounts for the year ended 24 July 2023
5
Tangible fixed assets
Total 
£ 
Cost or valuation
At 25 July 2022
13,998 
Additions
1,249 
At 24 July 2023
15,247 
Depreciation
At 25 July 2022
12,468 
Charge for the year
1,251 
At 24 July 2023
13,719 
Net book value
At 24 July 2023
1,528 
At 24 July 2022
1,530 
6
Average number of employees
During the year the average number of employees was 0 (2022: 0).
- 6 -